Posted Apr. 30, 2012 at 3:10 p.m.

Premium Lock Pozen runs into a headache with FDA over safer aspirin

Published: 2012-04-30 15:10:37
Updated: 2012-04-30 15:10:37

Print this blog post
Pozen's headaches

During a recent meeting with the FDA to discuss its submission, the agency suggested the Chapel Hill-based company also seek approval for the drug at a lower dose...

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll